Jim Cramer says Eli Lilly has checked the most important box as obesity pill approval looms
By Morgan Chittum
Published on March 11, 2026.
The CNBC Investing Club with Jim Cramer discusses key moments including the S & P 500 drifting lower and volatile oil prices. The February consumer price index report matched expectations, but the market was more concerned about the surge in energy prices as the International Energy Agency announced plans to release 400 million barrels of oil from reserves to address any supply disruptions. Meanwhile, CrowdStrike shares rose by roughly 1% due to concerns about AI agents and potential security breaches. Wolfe Research raised its price target on Eli Lilly to $1,325 from $1.250, suggesting roughly 32% upside from Tuesday's close. Despite this, Jim Crampton remains optimistic about the potential for Lilly's obesity pill, noting that the factories will be ready to meet the demand. Other notable moments included Campbell's, Cintas, CarMax and J.M. Smucker.
Related Articles
England Continues Cultural Erasure By Pulling Winston Churchill From Currency
The Bank of England is removing Winston Churchill from English banknotes, replacing him with Wild animals, amid cultural and racial sensitization concerns.
Jet fuel prices are trading around Russia-Ukraine highs in Europe and Asia, says Citi's Max Layton
Despite the rise in popularity, jet fuel prices remain volatile due to the IEA's decision to release barrels of oil, with prices rising above 50% in response.
Fong urges Newsom, CARB to reconsider cap-and-invest plan amid gas price concerns
Valley Congressman Vince Fong urges California leaders to reconsider cap-and-investing emissions policies, citing potential gas price increases and refinery shutdowns, risking national security and energy affordability.